Autres langues BCAL Diagnostics Limited

Actions

BDX

AU0000160921

Marché Fermé - Australian S.E. Autres places de cotation 08:10:41 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,092 ^AUD	+1,10 %		-3,16 %	-7,07 %

20/02	BCAL Diagnostics Limited publie ses résultats pour le semestre clos le 31 décembre 2023	CI
2023	BCAL Diagnostics s'associe pour mener une étude sur les tests sanguins du cancer du sein en Inde	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BCAL Diagnostics Appoints CEO	06/03
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	20/02
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India	29/11
BCAL Diagnostics Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Fall 5%	14/11
BCAL Diagnostics Files for Additional Australian Patent Application	06/11
BCAL Diagnostics Appoints COO	05/09/23
Bcal Diagnostics Limited Appoints Shane Ryan as Chief Operating Officer Effective 21 September 2023	05/09/23
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
9,246,318 Ordinary Options of BCAL Diagnostics Limited are subject to a Lock-Up Agreement Ending on 21-JUL-2023.	21/07/23
54,752,379 Ordinary Shares of BCAL Diagnostics Limited are subject to a Lock-Up Agreement Ending on 21-JUL-2023.	21/07/23
BCAL Diagnostics Appoints Advisor	16/05/23
Bcal Diagnostics Limited Opens New Laboratory in Sydney	04/05/23
BCAL Diagnostics Opens Laboratory in Sydney	03/05/23
BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
BCAL Diagnostics to Set Up Clinical Service Laboratory in Sydney	26/10/22
BCAL Diagnostics Limited Announces Establishment of Development & Clinical Service Laboratory	24/10/22
BCAL Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/08/22
BCAL Diagnostics Limited Enters US Product Development Agreement with Precion Inc	28/06/22
BCAL Files Foundational Patent Application	11/05/22
BCAL Files Foundational Patent Application	11/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BCAL Diagnostics Limited

Actions

BDX

AU0000160921

Autres langues

Filtres